Pricing Log in Create free account

BioNTech SE Sponsored ADR (BNTX) vs Roivant Sciences Ltd. (ROIV)

BioNTech SE Sponsored ADR and Roivant Sciences Ltd. are both Biotechnology companies. BioNTech SE Sponsored ADR and Roivant Sciences Ltd. are of similar size ($24.6B and $22.7B). BioNTech SE Sponsored ADR grew revenue faster over the last twelve months: −3.33% against −67.6%. BioNTech SE Sponsored ADR has the higher net margin (−65.8% vs −3,535.0%) and the lower return on invested capital (−38.4% vs −34.5%). Across the 18 metrics below, BioNTech SE Sponsored ADR leads on 10 and Roivant Sciences Ltd. on 8.

Valuation

Metric BNTX ROIV Biotechnology median
P/E n/m n/m 8.50
P/S 7.35 3,208.66 9.71
P/B 1.07 4.91 2.13
Price to free cash flow 44.31 n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 1.78 2,741.54 9.21
Earnings yield (8.94%) (1.13%) (33.15%)
Free cash flow yield 2.26% (3.40%) (25.50%)

Profitability

Metric BNTX ROIV Biotechnology median
Gross margin 75.24% 81.21% 65.16%
Operating margin (77.94%) (7,914.75%) 0.00%
Net margin (65.75%) (3,534.96%) 0.00%
Free cash flow margin 16.58% (10,901.00%) 0.00%
Return on equity (9.53%) (5.47%) (56.36%)
Return on assets (8.24%) (5.15%) (48.04%)
Return on invested capital (38.39%) (34.51%) 0.00%

Growth

Metric BNTX ROIV Biotechnology median
Revenue growth (TTM) (3.33%) (67.58%) 6.02%
EPS growth (last fiscal year) (77.33%) (125.00%) 30.26%
Revenue growth, 5-year CAGR 42.58% (19.07%) 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BNTX ROIV Biotechnology median
Debt to equity 0.02 0.00 0.00
Current ratio 7.85 16.72 4.72
Net debt to EBITDA 14.29 8.39 0.96

Dividend

Metric BNTX ROIV Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric BNTX ROIV Biotechnology median
Market cap 22.66b 24.59b 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack